Small Molecule LuxN Receptor Antagonists for Quorum Sensing Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions to control bacterial pathogenesis and biofilm formation by interfering with quorum sensing mechanisms, particularly in Gram-negative bacteria that utilize acyl-homoserine lactone-type autoinducers.
Innovation Solution
Identification and use of small molecules that bind to the LuxN receptor in Vibrio harveyi, disrupting the detection of AI-1 and inhibiting quorum sensing-mediated activities, including the development of pharmaceutical compositions and medical devices coated with these molecules to prevent bacterial infection and biofilm formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to control bacterial pathogenesis, then current treatment options are limited, but new effective solutions are needed to interfere with quorum sensing mechanisms
Solution Approach 1:
The patent introduces small molecule compounds as intermediary substances that bind to the LuxN receptor protein, blocking the interaction between the autoinducer AI-1 and its receptor. This mediator approach allows interference with quorum sensing without directly affecting bacterial growth or metabolism, resolving the contradiction between needing effective pathogenesis control and the lack of targeted quorum sensing interference tools
Solution Approach 2:
The patent modifies the binding parameters of the LuxN receptor by introducing competitive inhibitors that change the affinity and interaction dynamics between the receptor and autoinducer. By altering these molecular parameters, the system achieves effective quorum sensing interference while maintaining compatibility with existing bacterial physiological parameters
2Object-generated harmful factors
If small molecules bind to LuxN receptor to disrupt AI-1 detection, then quorum sensing-mediated activities are inhibited, but the mechanism complexity increases
Solution Approach 1:
The patent extracts the critical binding interface between the LuxN receptor and AI-1 autoinducer, and introduces small molecule compounds that specifically target this interface. By isolating and disrupting this specific interaction point, the system achieves effective inhibition of quorum sensing-mediated pathogenicity without requiring complex multi-component systems
Solution Approach 2:
The patent employs small molecule compounds that are simple, chemically defined, and can be easily administered. These molecular agents provide effective quorum sensing interference with minimal complexity, avoiding the need for complex protein-based inhibitors or multi-step treatment protocols
3Ease of manufacture
If pharmaceutical compositions are developed with quorum sensing inhibitors, then bacterial infections can be treated, but the development complexity increases
Solution Approach 1:
The patent identifies small molecule compounds that can target the LuxN receptor across different bacterial species that utilize homoserine lactone quorum sensing. This universal mechanism allows a single compound class to treat multiple types of infections, simplifying pharmaceutical development by reducing the need for species-specific treatment protocols
Solution Approach 2:
The patent performs preliminary characterization of the LuxN receptor binding interface and identifies lead compounds through structured screening. This preliminary work establishes a foundation for efficient pharmaceutical development, reducing the complexity of later clinical translation by pre-validating the mechanism and selecting optimal candidates
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The small molecules effectively inhibit bacterial pathogenicity and biofilm formation by disrupting quorum sensing, rendering bacteria non-pathogenic and preventing undesirable communal bacterial activities, thus offering a novel approach to treat infections and control bacterial growth.
Implementation Method 1
small molecules that bind to the LuxN receptor in Vibrio harveyi, disrupting the detection of AI-1
Data Source
AI summary
Methods are provided for identifying molecules that can be used to positively and negatively manipulate quorum-sensing-mediated communication to control bacterial behavior. Small-molecule antagonists that disrupt quorum-sensing-mediated activities are identified. Methods are provided for disrupting detection of acyl-homoserine lactone autoinducer in Gram-negative bacteria by contacting the bacteria with the antagonists. Methods of inhibiting quorum sensing-mediated activity in Gram-negative bacteria are provided wherein the activity is pathogenicity, bioluminescence, siderophore production, type III secretion, or metalloprotease production.